IGNATIA AMARA

STRYCHNOS IGNATII SEED ORAL HUMAN OTC DRUG

IGNATIA AMARA is an FDA drug label for the active ingredient STRYCHNOS IGNATII SEED manufactured by Hyland's Inc. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20221219.

Generic name
STRYCHNOS IGNATII SEED
Manufacturer
Hyland's Inc.
Product type
HUMAN OTC DRUG
Route
ORAL
Dosage form
N/A
NDC
54973-2916
Application
N/A
Label effective
20221219

Active ingredients

IGNATIA AMARA 30X

Indications & Usage

SIMPLE NERVOUS TENSION OR STOMACH CRAMPS

Dosage & Administration

Directions Adults: Dissolve 4 tablets under tongue 4 times a day. Children: consult a healthcare professional.

Contraindications

Not available.

Warnings

Warnings Do not use if cap band is missing or broken. If you are pregnant or nursing, consult a licensed health care professional before using this product. If symptoms persist for 7 days or worsen, contact a licensed practitioner. Keep this and all medicines out of the reach of children. To be used according to label indications and/or standard homeopathic indications.

Adverse Reactions

Not available.